MediWound Ltd. cash flow to debt ratio of -178.24% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

MediWound Ltd.'s free cash flow has decreased 0.69% from $-19.90M last year to $-20.04M, signaling decreasing performance

MediWound Ltd.'s debt to equity ratio is 0.20, which means that the company's assets are healthy financed, signaling financial stability.

MediWound Ltd.'s debt has decreased relative to shareholder equity from 0.22 last year to 0.20 today, signaling strengthened financials

MediWound Ltd. has a net cash position, so leverage is healthy.

MediWound Ltd. earns at least as much interest as it pays. Interest obligations are fully covered.

MediWound Ltd.'s profit margin has decreased (20.63%) in the last year from -149.46% to -180.30%, signaling decreasing performance

MediWound Ltd.'s short-term assets of $59.96M exceed its short-term liabilities of $25.71M

MediWound Ltd.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

MediWound Ltd.'s return on equity of -67.22%, is lower than 15.00%, indicating bad performance

MediWound Ltd.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

MediWound Ltd. had positive net income in only 0 out of 5 years, indicating unstable earnings

MediWound Ltd. has negative free cash flow, indicating the company is burning cash rather than generating it

MediWound Ltd. has negative free cash flow, indicating cash burn

MediWound Ltd.'s yearly earnings has increased -20.99% since last year from $-30.22M to $-23.88M, signaling increasing performance

MediWound Ltd.'s yearly revenue has decreased 16.14% since last year from $20.22M to $16.96M, signaling decreasing performance

ROIC -47.30% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

MediWound Ltd.'s 3-year revenue CAGR of -13.82% is negative, indicating declining revenue over the past 3 years

MediWound Ltd. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

MediWound Ltd. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

MediWound Ltd. has insufficient data to evaluate this check.

MediWound Ltd. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

MediWound Ltd. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

MediWound Ltd. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

MediWound Ltd. is overvalued relative to its fair value price of -8.30 based on Earnings Fair Value model

MediWound Ltd. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

MediWound Ltd. has a price-to-book ratio of 4.30x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

MediWound Ltd. has a price-to-sales ratio of 12.30x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue